Jacobus, N V <br/><br/>
Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactam.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Jun 1993 
 - S344-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1058-4838 
<br/><br/><label>Standard No.: </label>10.1093/clinids/16.supplement_4.s344  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bacteria, Anaerobic--drug effects<br/>Bacterial Infections--drug therapy<br/>Drug Resistance, Microbial<br/>Drug Therapy, Combination--administration & dosage<br/>Humans<br/>In Vitro Techniques<br/>Microbial Sensitivity Tests<br/>Penicillanic Acid--administration & dosage<br/>Piperacillin--administration & dosage<br/>Tazobactam<br/>beta-Lactamase Inhibitors